Early outcomes among those initiating chronic dialysis in the united states

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 11, 2011, Pages 2642-2649

  Chan, Kevin E ^a,b   Maddux, Frank W ^a   Tolkoff Rubin, Nina ^b   Karumanchi, S Ananth ^c   Thadhani, Ravi ^b   Hakim, Raymond M ^a  

^a Fresenius Medical Care   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Beth Israel Deaconess Medical Center   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; TIME SERIES ANALYSIS; UNITED STATES; VASCULAR ACCESS;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 80655126754     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03680411     Document Type: Article

References (31)

1. Incident and prevalent counts by quarter: United States Renal Data System. http://www.usrds.org/qtr/qrt_report_table_c_01_
2. U.S. Renal Data System, USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
3. Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS: Current status of kidney and pan-creas transplantation in the United States, 1994 -2003. Am J Transplant 5: 904-915, 2005
4. The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Annual Report 2008. http://optn.transplant.hrsa.gov/ar2008/, accessed 10/15/10
5. Nissenson AR, Rettig RA: Medicare's end-stage renal disease program: Current status and future prospects. Health Aff (Millwood) 18: 161-179, 1999
6. Levinsky NG: The organization of medical care. Lessons from the Medicare end stage renal disease program. N Engl J Med 329: 1395-1399, 1993
7. Iglehart JK: The American health care system. The End Stage Renal Disease Program. N Engl J Med 328: 366-371, 1993
8. Centers for Medicare & Medicaid Services: Medicare Coverage of Kidney Dialysis and Kidney Transplant Services. www.medicare.gov/Publications/Pubs/pdf/10128.pdf, accessed 10/ 15/10
9. Wetmore JB, Rigler SK, Mahnken JD, Mukhopadhyay P, Shireman TI: Considering health insurance: How do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage? Nephrol Dial Transplant 25: 198-205, 2010
10. Himmelfarb J, Ikizler TA: Hemodialysis. N Engl J Med 363:1833-1845, 2010
11. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraen-kel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363: 609 - 619, 2010
12. Collins AJ, Foley RN, Gilbertson DT, Chen SC: The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 4[Suppl 1]: S5-S11, 2009
13. Wingard RL, Pupim LB, Krishnan M, Shintani A, Ikizler TA, Hakim RM: Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol 2: 1170-1175, 2007
14. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2: 89-99, 2007
15. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584 -590, 1998.
16. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes melli-tus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
17. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannis-ter K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronha-gen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407, 2009
18. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
19. Khan IH, Catto GR, Edward N, MacLeod AM: Death during the first 90 days of dialysis: A case control study. Am J Kidney Dis 25: 276-280, 1995
20. Soucie JM, McClellan WM: Early death in dialysis patients:Risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 7: 2169-2175, 1996
21. United States Census Bureau: 2000 Census summary files. Washington, D.C.: Department of Commerce.
22. Ingelfinger JR, Drazen JM: Registry research and medical privacy. N Engl J Med 350: 1452-1453, 2004
23. US Renal Data System: Excerpts from United States Renal Data System: USRDS 1990 Annual Data Report, Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1990
24. US Renal Data Systems, USRDS 2010 Annual Data Report:Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Disease, 2010
25. U.S. Renal Data System: USRDS 2008 Annual Data Report:Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
26. Chan KE, Lazarus JM, Wingard RL, Hakim RM: Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge. Kidney Int 76: 331-341, 2009
27. Davita Impact. https://sharedapp.davita.com/webapps/Impact/about.cfm/, accessed 6/27/11
28. Himmelfarb J, Kliger AS: End-stage renal disease measures of quality. Annu Rev Med 58: 387-399, 2007
29. Slinin Y, Guo H, Gilbertson DT, Mau LW, Ensrud K, Collins AJ, Ishani A: Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis. Am J Kidney Dis Available online 29 June 2011
30. Lacson E, Jr, Wang W, Devries C, Leste K, Hakim RM, Lazarus M, Pulliam J: Effects of a nationwide predialysis educational program on modality choice, vascular access, and patient outcomes. Am J Kidney Dis 58: 235-242, 2011
31. Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S176 -S247, 2006